Literature DB >> 11282543

The 3' untranslated region of tumor necrosis factor-alpha is highly conserved in idiopathic pulmonary fibrosis (IPF).

R W Freeburn1, H Kendall, L Dobson, J Egan, N J Simler, A B Millar.   

Abstract

Tumour necrosis factor alpha (TNF-alpha), a pro-inflammatory cytokine essential for the function of the immune system, has been implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF). Production of TNF-alpha is regulated at both the transcriptional and post-transcriptional levels by a number of factors including interleukin-10 (IL-10). We have shown that there is significant TNF-alpha activity in patients with IPF, despite the presence of significant amounts of IL-10 and Il-10R. IL-10 is thought to influence the tight translational repression of TNF-alpha mRNA in pulmonary macrophages. The essential element in this regulation is the AU-rich element (ARE) present in the 3' untranslated region of TNF-alpha. We hypothesised that polymorphism in the 3' UTR region of TNF-alpha explains the apparent failure of IL-10 to down regulate TNF-alpha in patients with IPF. Using single strand conformation polymorphism (SSCP) analysis, we have screened this region in 96 patients with IPF, using nine sets of overlapping PCR primers. All samples were successfully amplified for each primer set, but SSCP analysis was unable to detect point mutations or polymorphisms in the patients in any of the nine fragments. Results from this study suggest that the 3' UTR region of TNF-alpha is highly conserved in IPF and mutation of this region is unlikely to be involved in the pathogenesis of IPF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282543

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  7 in total

1.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

2.  Genetic analysis of sporadic and familial interstitial pneumonia.

Authors:  David A Schwartz
Journal:  Proc Am Thorac Soc       Date:  2008-04-15

3.  Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis.

Authors:  Moises Selman; Hung-Mo Lin; Martha Montaño; Audrey L Jenkins; Andrea Estrada; Zhenwu Lin; Guirong Wang; Susan L DiAngelo; Xiaoxuan Guo; Todd M Umstead; C Max Lang; Annie Pardo; David S Phelps; Joanna Floros
Journal:  Hum Genet       Date:  2003-09-06       Impact factor: 4.132

4.  Smoking and idiopathic pulmonary fibrosis.

Authors:  Chad K Oh; Lynne A Murray; Nestor A Molfino
Journal:  Pulm Med       Date:  2012-02-19

Review 5.  Surfactant gene polymorphisms and interstitial lung diseases.

Authors:  Panagiotis Pantelidis; Srihari Veeraraghavan; Roland M du Bois
Journal:  Respir Res       Date:  2001-11-29

6.  Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis.

Authors:  Esam H Alhamad; Joseph G Cal; Zahid Shakoor; Adel Almogren; Ahmad A AlBoukai
Journal:  BMC Med Genet       Date:  2013-07-01       Impact factor: 2.103

Review 7.  Genomics of Human Fibrotic Diseases: Disordered Wound Healing Response.

Authors:  Rivka C Stone; Vivien Chen; Jamie Burgess; Sukhmani Pannu; Marjana Tomic-Canic
Journal:  Int J Mol Sci       Date:  2020-11-14       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.